Budenofalk 4 mg Zäpfchen, placebo to test
BUS-006/RAP
Phase 2 small_molecule active
Quick answer
Budenofalk 4 mg Zäpfchen, placebo to test for Acute radiation proctitis symptoms in male patients aged 18 years or older with prostate carcinoma is a Phase 2 program (small_molecule) at Dr. Falk Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dr. Falk Pharma GmbH
- Indication
- Acute radiation proctitis symptoms in male patients aged 18 years or older with prostate carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active